뉴스기사물 (10)
CAMBRIDGE, MASS. & BREA, CALIF. & TOKYO--(Business Wire / Korea Newswire)--Biogen Inc. (Nasdaq: BIIB), Beckman Coulter, Inc. and Fujirebio announced a collaboration to potentially identify and develop blood-based biomarkers for tau pathology in the...
건강제휴회계/세무해외 케임브리지, 매사추세츠 & 브레아, 캘리포니아 & 도쿄--(Business Wire / 뉴스와이어)--바이오젠(Biogen Inc.)(나스닥: BIIB)과 벡크만 쿨터(Beckman Coulter, Inc.), 후지레비오(Fujirebio)는 뇌의 타우 병리학을 위한 혈액 기반 생체표지자를 잠재적으로 식별 및 개발하고, 알츠하이머병(AD)에서 타우 병리학을 위한 새로운 검사를...
ZUG, SWITZERLAND--(Business Wire / Korea Newswire)--Galderma today announced that it has completed its European decentralized procedure (DCP), resulting in a positive decision for Relfydess™ (RelabotulinumtoxinA - previously referred to as QM1114). Relfydess™ is indicated...
SAN JOSE, CALIF.--(Business Wire / Korea Newswire)--Cepton, Inc. (“Cepton” or the “Company”) (Nasdaq: CPTN), a Silicon Valley innovator and leader in high performance lidar solutions, announced today that it has signed a definitive agreement...
PALO ALTO, CALIF.--(Business Wire / Korea Newswire)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the U.S. Food and Drug Administration (FDA) has approved the company’s Shield™ blood test for colorectal...
RIOMAGGIORE, ITALY--(Business Wire / Korea Newswire)--After a long wait, on Saturday, July 27th, the Via dell’Amore will reopen to the public. With just over 900 metres of trail perched over the sea, this iconic...
NOVI, MICH--(Business Wire / Korea Newswire)--Lineage, Inc. (the “Company”) (Nasdaq: LINE) today announced the closing of its underwritten initial public offering of 56,882,051 shares of its common stock at a public offering price of...
CHICAGO--(Business Wire / Korea Newswire)--NielsenIQ (NIQ), the world’s leading consumer intelligence company, has released its second Environmental, Social and Governance (ESG) Progress Report detailing the Company’s ESG priorities, how it embeds inclusive, sustainable principles...
NEUILLY-SUR-SEINE, FRANCE--(Business Wire / Korea Newswire)--Hinda Gharbi, Chief Executive Officer, commented: “In the first half of the year, we kick started the execution of our LEAP I 28 strategy which was launched at the...
ZUG, SWITZERLAND--(Business Wire / Korea Newswire)--Galderma today announced that full results from the phase III ARCADIA 1 and 2 clinical trials in atopic dermatitis were published in The Lancet.[1]The trials evaluated the efficacy and...
